NATURAL PRODUCT RESEARCH
5
3
.3. Chromatographic and spectroscopic methods
Preparative HPLC was carried out on a P270 preparative HPLC system (Chinese Dalian Elite)
with ZORBAX Eclipse XOB-C18 Prep HT 21.2 × 150 mm 5 μm column (Agilent). HPLC was
®
carried out on a LC-20AT HPLC (Shimadzu) with an Inertsil ODS-SP 4.6 × 150 mm 5 μm
column (Shimadzu).
Melting points were determined on a microscopic melting point determination apparatus
(
Reichert). UV spectra were recorded on a UV-1800 spectrophotometer (Shimadzu), and IR
spectra were recorded on a VERTEX70 FT-IR spectrometer (Bruker, Germany). MS and HRMS
were obtained with 1100 LC/MSD Trap XCT (Agilent, USA) and a 4800 Plus MALDI TOF/TOF™
1
13
Analyzer. H and C NMR spectra, HSQC and HMBC were recorded on a Unity-Inova 600 or
Mercury VX-300 superconducting magnetic resonance spectrometer (Varian, USA). 1H-1H
COSY and NOESY were recorded on Bruker Avance III 600 NMR spectrometer equipped with
a TCI cryoprobe.
3
.4. Characterisation
1
0-O-(1-β-D-glycosyl) camptothecin (1): white flocculent crystal, mp 228–232 °C,
−
1
tR = 4.2 min (HPLC, CH CN/H O, 18:82, 1 mL min , 256 nm); ESI-MS m/z:+MS: 527.0
3
2
+
+
+
+
[
M + H] , 365.0 [M-162 + H] , 321.1 [M-162-CO2 + H] , 1052.8 [2 M + H] ; HR-ESI-MS:
m/z = 527.173; UV (MeOH) λmax: 221 nm, 263 nm, 293 nm, 311 nm, 328 nm, 364 nm,
−
1
3
1
78 nm; IR (KBr) υmax (cm )=3392 (broad), 2926, 1740, 1655, 1622, 1590, 1504, 1370,
1
240, 1212, 1164, 1075, 1047; H NMR (600 MHz, DMSO-d6): δ 5.26 (2H, s, H-5), 8.53 (1H,
s, H-7), 7.64 (1H, s, H-9), 7.57 (1H, d, J = 9 Hz, H-11), 8.08 (1H, d, J = 9 Hz, H-12), 7.28 (1H,
s, H-14), 5.42 (2H, s, H-17), 0.88 (3H, t, J = 7.2 Hz, H-18), 1.86 (2H, m, H-19), 5.13 (1H, d,
J = 4.2 Hz, Glc-1′), 3.50–3.24 (4H, m, Glc-2′, 3′, 4′, 5′), 3.75(1H, m) and 3.52(1H, m) (Glc-
6
′), 6.54 (1H, s, 20-OH), 4.659 (1H, t, J = 5.4, 6′-OH), 5.484 (1H, s), 5.199 (1H, s) and 5.127
1
13
(
(
1H, s) (2′,3′,4′-OH); H NMR (600 MHz, CD OD): δ 5.11 (1H, d, J = 7.8 Hz, Glc-1′); C NMR
600 MHz, DMSO-d6): δ 151.12 (C-2), 146.03 (C-3), 50.67 (C-5), 130.59(C-6), 130.85 (C-7),
3
1
29.47 (C-8), 110.79 (C-9), 156.38 (C-10), 123.45 (C-11), 130.79 (C-12), 144.66 (C-13), 96.67
(
C-14), 150.44 (C-15), 118.93 (C-16), 65.66 (C-17), 8.21 (C-18), 30.64(C-19), 72.82 (C-20),
1
7
72.99 (C-21), 157.24 (C-22), 100.57 (Glc-1′), 73.63 (Glc-2′), 77.62 (Glc-3′), 70.04 (Glc-4′),
7.07 (Glc-5′), 61.05 (Glc-6′).
Syringaresinol-4,4′-O-bis-β-D-glucoside (2): White powder (methanol-acetone), mp 255–
−1
2
57 °C. tR = 4.18 min (HPLC, CH CN/H O, 18:82, 1 mL min , 256 nm), ESI-MS m/z:+ MS:765
3 2
+
2
+
3
+
[
[
M + Na] , + MS (765): 603 [M-162 + Na] , + MS (765→603): 441 [M-2 × 162 + Na] , 185
+ − 2 -
162 + Na] , 235;-MS:777 [M + Cl] , -MS (777): 579 [M-H-162] , 417 [M-2 × 162-H]. UV (MeOH)
−1
λmax: 212 nm, 272 nm; IR (KBr) υmax (cm ): 3393 (-OH), 2923 (CH , CH ), 2864, 1595, 1508,
2
3
1
1464, 1422, 1379, 1336, 1237, 1132, 1074, 1024, 993. H NMR (600 MHz, D O): δ 6.69 (4H, s,
2
H-2, 2′, 6, 6′), 4.78 (2H, s, H-7, 7′), 3.22 (2H, m, H-8, 8′), 3.88 (2H,d, J = 7.8 Hz, H-9a, 9′a), 4.22
(
(
5
1
2H, dd, J = 7.2,7.2 Hz, H-9e, 9′e), 3.76 (12H, s, OCH ), 4.90 (2H, d, J = 7.2 Hz, Glc-1″, 1‴), 3.18
3
2H, s), 3.36 (2H, dd) and 3.43 (4H, m) (Glc-2″, 2‴, 3″, 3‴, 4″, 4‴, 5″, 5‴), 3.58 (2H, dd, J = 12.6,
1
3
.4 Hz, Glc-6″, 6‴), 3.69 (2H,d, J = 12 Hz, Glc-6″, 6‴). C NMR (600 MHz, D O): δ 138.5 (C-1,
2
′), 104.5 (C-2, 2′, 6, 6′), 153.0 (C-3, 3′, 5, 5′), 133.5 (C-4, 4′), 86.1 (C-7, 7′), 53.6 (C-8, 8′), 72.1
(
5
C-9, 9′), 56.8 (OCH ), 103.4 (C-1’ ’, 1‴), 74.1 (C-2″, 2‴), 76.7 (C-3″, 3‴), 69.8 (C-4″, 4‴), 76.1 (C-5″,
3
‴), 61.0 (C-6″, 6‴).